• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percentage of NDI notification reviews completed during the month within 75 days of filing

Dictionary: Timely review of notifications of new dietary ingredients impacts the public health by preventing substances that are not actually dietary ingredients from being used in dietary supplements, and assuring that new dietary ingredients have adequate evidence for presumption of safety. Since these statutory requirements are notifications rather than pre-market approvals, it is essential that ONLDS have completed review of the information before the submitter markets the product, to notify them of any safety or regulatory concerns before the product reaches consumers.

Information is current as of June 30, 2014.

Fiscal Year - 2011

Skip graphic and jump to text data

TimeAnnual TargetPercentage
Oct 201090100
Nov 201090100
Dec 201090100
Jan 201190100
Feb 20119088
Mar 201190100
Apr 201190100
May 201190100
Jun 201190100
Jul 201190100
Aug 201190100
Sep 20119075

FY 2011 Overall: 96%

Number of NDI notification reviews due to be completed during the month

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2010N/A5
Nov 2010N/A1
Dec 2010N/A3
Jan 2011N/A4
Feb 2011N/A8
Mar 2011N/A3
Apr 2011N/A8
May 2011N/A2
Jun 2011N/A3
Jul 2011N/A4
Aug 2011N/A7
Sep 2011N/A4

FY 2011 Total: 52

Number of NDI notification reviews completed during the month within 75 days of filing

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2010N/A5
Nov 2010N/A1
Dec 2010N/A3
Jan 2011N/A4
Feb 2011N/A7
Mar 2011N/A3
Apr 2011N/A8
May 2011N/A2
Jun 2011N/A3
Jul 2011N/A4
Aug 2011N/A7
Sep 2011N/A3

FY 2011 Total: 50

Total number of NDI notification reviews completed during the month

Fiscal Year - 2011
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2010N/A5
Nov 2010N/A1
Dec 2010N/A3
Jan 2011N/A4
Feb 2011N/A8
Mar 2011N/A3
Apr 2011N/A8
May 2011N/A2
Jun 2011N/A3
Jul 2011N/A4
Aug 2011N/A7
Sep 2011N/A4

FY 2011 Total: 52

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.